Cargando…
Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
BACKGROUND AND PURPOSE: Anti-muscle-specific kinase (MuSK) positive myasthenia gravis (MG) is characterized by a high relapsing rate, thus, choosing the appropriate oral drug regimen is a challenge. This study aimed to evaluate the efficacy of oral immunosuppressants (IS) in preventing relapse in Mu...
Autores principales: | Tan, Ying, Shi, Jiayu, Huang, Yangyu, Li, Ke, Yan, Jingwen, Zhu, Li, Guan, Yuzhou, Cui, Liying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237788/ https://www.ncbi.nlm.nih.gov/pubmed/35775051 http://dx.doi.org/10.3389/fneur.2022.877895 |
Ejemplares similares
-
Treatment of insomnia in myasthenia gravis—A prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia
por: Yan, Jingwen, et al.
Publicado: (2023) -
Patients With Myasthenia Gravis With Acute Onset of Dyspnea: Predictors of Progression to Myasthenic Crisis and Prognosis
por: Huang, Yangyu, et al.
Publicado: (2021) -
Iron metabolism patterns in non-anemic patients with myasthenia gravis: A cross-sectional and follow-up study
por: Li, Ke, et al.
Publicado: (2022) -
Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review
por: Shi, Jiayu, et al.
Publicado: (2022) -
Reappraisal of Oral Steroid Therapy for Myasthenia Gravis
por: Imai, Tomihiro, et al.
Publicado: (2020)